Susquehanna Fundamental Investments, LLC Milestone Pharmaceuticals Inc. Transaction History

Susquehanna Fundamental Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.86 - $9.43 $72,400 - $116,507	-12,355 Reduced 51.79%	11,499 $106,000
Q1 2022 May 16, 2022	SELL	$4.1 - $8.24 $32,750 - $65,821	-7,988 Reduced 25.09%	23,854 $153,000
Q4 2021 Feb 14, 2022	SELL	$5.47 - $7.13 $43,541 - $56,754	-7,960 Reduced 20.0%	31,842 $209,000
Q3 2021 Nov 15, 2021	SELL	$5.28 - $6.29 $61,776 - $73,593	-11,700 Reduced 22.72%	39,802 $227,000
Q2 2021 Aug 11, 2021	SELL	$5.22 - $6.11 $47,684 - $55,814	-9,135 Reduced 15.07%	51,502 $283,000
Q1 2021 May 17, 2021	SELL	$5.79 - $8.85 $102,239 - $156,273	-17,658 Reduced 22.55%	60,637 $351,000
Q4 2020 Feb 16, 2021	SELL	$5.57 - $7.66 $38,210 - $52,547	-6,860 Reduced 8.06%	78,295 $525,000
Q3 2020 Nov 16, 2020	BUY	$3.34 - $9.8 $151,151 - $443,499	45,255 Added 113.42%	85,155 $623,000
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.56 $70,623 - $181,943	39,900 New	39,900 $151,000

25.1M

61.2K

38.8K

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $48.9M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.